All Regulatory Rapporteur articles in September 2024
View all stories from this issue.
-
Industry newsNew Editor-in-Chief for Regulatory Rapporteur
Victoria Goff has been announced as the new Editor-in-Chief of Regulatory Rapporteur.
-
Industry newsWHO issues warning on fake opioids in Europe
The World Health Organization (WHO) has issued an alert that falsified Oxymorphone Hydrochloride has been detected in Finland.
-
Industry newsContraindication for mixing weight loss medicine Mysimba with opioids
The European Medicines Agency (EMA) published new advice in July 2024 concerning the combined use of opioid medications and the weight loss drug Mysimba (naltrexone/bupropion).
-
Industry newsUK pledges to join the Trans-Pacific Partnership by end of 2024
The UK’s Minister of State for Trade Policy announced on 29 August 2024 that the UK will be joining the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP) by 15 December.
-
Industry newsNICE and EMA say new Alzheimer’s drug is ‘not recommended’
The new draft guidance from NICE states that Lecanemab is ‘not recommended’ and the EMA has recommended the refusal of the marketing authorisation for Leqembi.
-
-
-
-
-
-
-
-
